Premium
A novel region of amplification at 11p12‐13 in gastric cancer, revealed by representational difference analysis, is associated with overexpression of CD44v6, especially in early‐onset gastric carcinomas
Author(s) -
Carvalho Ralph,
Milne Anya N. A.,
Polak Mirjam,
Offerhaus G. Johan A.,
Weterman Marian A. J.
Publication year - 2006
Publication title -
genes, chromosomes and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.754
H-Index - 119
eISSN - 1098-2264
pISSN - 1045-2257
DOI - 10.1002/gcc.20360
Subject(s) - cd44 , biology , cancer , tissue microarray , gene duplication , pathology , histology , immunohistochemistry , gene , southern blot , microbiology and biotechnology , cancer research , medicine , genetics , in vitro
Diffuse‐type gastric carcinomas (GCs) are often difficult to characterize because of contamination of tumor samples by surrounding normal tissue. As such, information regarding chromosomal aberrations in this subtype of GCs is limited. In this study, we used representational difference analysis to pinpoint genomic amplifications occurring in diffuse‐type GCs. We found nine differential products from two novel regions of amplification in two tumors: one product mapped to 19p13.1 and eight mapped to a 1.8‐Mb region in chromosomal segment 11p12‐13. These amplifications were confirmed using Southern blot analysis and occurred in 3/16 and 6/15 diffuse‐type GCs, respectively. CD44, a well characterized cellular adhesion molecule involved in several human malignancies, is encoded by a gene located within 200 kb of the 11p12‐13 amplification fragments. We confirmed that overexpression of isoform CD44v6 was correlated with amplification at 11p12‐13 in 11/12 diffuse‐type GCs. Since diffuse‐type GCs occur more frequently in early‐onset gastric carcinomas (EOGCs, presented at 45 years of age or younger) than in “conventional” GCs, and the tumors carrying the original amplifications were EOGCs, we investigated overexpression of CD44v6 in 107 EOGCs and 88 conventional GCs using tissue microarrays. We found frequent CD44v6 overexpression in both tumor groups (76% and 57% respectively) and, interestingly, significantly more cases with overexpression of CD44v6 in EOGCs than in conventional GCs ( P = 0.005), irrespective of histology. These findings provide further evidence for both the relevance of CD44 in GC and for distinct molecular characteristics of EOGCs when compared with those of GCs occurring at a later age. © 2006 Wiley‐Liss, Inc.